Ischemic Preconditioning on Swimming Performance: An Exploration into Practical Application

Topics in Exercise Science and Kinesiology Volume 4: Issue 1, Article 14, 2023. Ischemic preconditioning (IPC), in exercise science, is the practice of repeatedly creating an ischemic event within a limb before exercise in an effort to improve athletic ability. The athletic aid, currently under review for its applicability to aerobic sports, has garnered conflicting results in the last decade of study. This research investigated the effects of IPC over distances of 250 and 500 yards while imposing commonly suggested methodologies. Sixteen college-aged swimmers, either recreational or competitive, were given IPC treatment with individualized limb occlusion pressure (ILOP) accompanied by a sham protocol. Participants were requested to give maximal effort during the trials, and pain and exertion scores were collected at multiple points. Results showed that the distance of 250 yards (p-value = 0.02) was improved by the IPC treatment, but the distance of 500 yards was not (p-value = 0.53). There was no significant variation in the visual analog scale (VAS) or rating of perceived exertion (RPE) for either distance. Measurement of ILOP found 25% of participants needed higher pressure than standardized pressure some studies utilize and 19% required pressure 40 mmHg below the standard. It was concluded that IPC may have a short period of benefit corresponding to the improvement seen in the 250 yard swim and that ILOP should be used over a standard pressure

Evaluation of Two Implant Strategies, Revalor- XH or a Combination Revalor- IH/Revalor- 200 on Heifer Growth Performance and Carcass Characteristics

A commercial feedlot trial examined effects of two implant strategies (Revalor- IH on d 1 and re- implanted with Revalor- 200 on d 101 or Revalor- XH on d 1) on growth performance and carcass characteristics of heifers fed 183 days. Th ere were no differences between implant strategies for final body weight, dry matter intake, and average daily gain. Heifers implanted with the combination IH/200 treatment had improved carcassadjusted feed conversion, greater LM area, and lower calculated yield grade compared to heifers implanted with XH. Th e response in growth performance between the two implant strategies suggests that the partiallycoated Revalor- XH implant can be used in place of a more aggressive implant strategy when heifers are fed to similar days

Tuning π-Acceptor/σ-Donor Ratio of the 2-Isocyanoazulene Ligand: Non-Fluorinated Rival of Pentafluorophenyl Isocyanide and Trifluorovinyl Isocyanide Discovered

Isocyanoazulenes (CNAz) constitute a relatively new class of isocyanoarenes that offers rich structural and electronic diversification of the organic isocyanide ligand platform. This article considers a series of 2-isocyano-1,3-X2-azulene ligands (X = H, Me, CO2Et, Br, and CN) and the corresponding zero-valent complexes thereof, [(OC)5Cr(2-isocyano-1,3-X2-azulene)]. Air- and thermally stable, X-ray structurally characterized 2-isocyano-1,3-dimethylazulene may be viewed as a non-benzenoid aromatic congener of 2,6-dimethyphenyl isocyanide (2,6-xylyl isocyanide), a longtime “workhorse” aryl isocyanide ligand in coordination chemistry. Single crystal X-ray crystallographic {Cr–CNAz bond distances}, cyclic voltametric {E1/2(Cr0/1+)}, 13C NMR {δ(13CN), δ(13CO)}, UV-vis {dπ(Cr) → pπ*(CNAz) Metal-to-Ligand Charge Transfer}, and FTIR {νN≡C, νC≡O, kC≡O} analyses of the [(OC)5Cr(2-isocyano-1,3-X2-azulene)] complexes provided a multifaceted, quantitative assessment of the π-acceptor/σ-donor characteristics of the above five 2-isocyanoazulenes. In particular, the following inverse linear relationships were documented: δ(13COtrans) vs. δ(13CN), δ(13COcis) vs. δ(13CN), and δ(13COtrans) vs. kC≡O,trans force constant. Remarkably, the net electron withdrawing capability of the 2-isocyano-1,3-dicyanoazulene ligand rivals those of perfluorinated isocyanides CNC6F5 and CNC2F3

Eff ect of Revalor- XH, Revalor- 200, and Combination Revalor- IH/Revalor- 200 on Yearling Heifer Growth Performance and Carcass Characteristics

A commercial feedlot trial tested three implant strategies (Revalor- 200 on day 0, Revalor- IH on d 0 and re- implanted with Revalor- 200 on d 56, or Revalor- XH on d 0) on growth performance and carcass characteristics of heifers fed for 138 d. Th ere were no differences observed for final body weight, dry matter intake, or average daily gain on a live basis among implant strategies. Heifers implanted with Revalor- IH/200 combination had greater carcass- adjusted final body weight and improved feed conversion compared to Revalor- 200 and Revalor- XH. Hot carcass weights, dressing percent, and LM area were improved for Revalor- IH/200 implanted heifers relative to Revalor- 200 and Revalor- XH implanted heifers. Marbling score and 12th- rib fat thickness were not different among implant treatments. Heifers implanted with Revalor- IH/200 had a shift to a lower USDA yield grade distribution compared to 200 and XH implanted heifers. Th e greater concentration of trenbolone acetate and estradiol provided by Revalor- IH/200 combination slightly improved growth and carcass performance compared to the non- coated Revalor- 200 implant and partially coated Revalor- XH implant

Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection

Marburg virus (family Filoviridae) causes sporadic outbreaks of severe hemorrhagic disease in sub-Saharan Africa. Bats have been implicated as likely natural reservoir hosts based most recently on an investigation of cases among miners infected in 2007 at the Kitaka mine, Uganda, which contained a large population of Marburg virus-infected Rousettus aegyptiacus fruit bats. Described here is an ecologic investigation of Python Cave, Uganda, where an American and a Dutch tourist acquired Marburg virus infection in December 2007 and July 2008. More than 40,000 R. aegyptiacus were found in the cave and were the sole bat species present. Between August 2008 and November 2009, 1,622 bats were captured and tested for Marburg virus. Q-RT-PCR analysis of bat liver/spleen tissues indicated ,2.5% of the bats were actively infected, seven of which yielded Marburg virus isolates. Moreover, Q-RT-PCR-positive lung, kidney, colon and reproductive tissues were found, consistent with potential for oral, urine, fecal or sexual transmission. The combined data for R. aegyptiacus tested from Python Cave and Kitaka mine indicate low level horizontal transmission throughout the year. However, Q-RT-PCR data show distinct pulses of virus infection in older juvenile bats (,six months of age) that temporarily coincide with the peak twiceyearly birthing seasons. Retrospective analysis of historical human infections suspected to have been the result of discrete spillover events directly from nature found 83% (54/65) events occurred during these seasonal pulses in virus circulation, perhaps demonstrating periods of increased risk of human infection. The discovery of two tags at Python Cave from bats marked at Kitaka mine, together with the close genetic linkages evident between viruses detected in geographically distant locations, are consistent with R. aegyptiacus bats existing as a large meta-population with associated virus circulation over broad geographic ranges. These findings provide a basis for developing Marburg hemorrhagic fever risk reduction strategies.The Department of Health and Human Serviceshttp://www.plospathogens.or

Single-Turnover Variable Chlorophyll Fluorescence as a Tool for Assessing Phytoplankton Photosynthesis and Primary Productivity: Opportunities, Caveats and Recommendations

Phytoplankton photosynthetic physiology can be investigated through single-turnover variable chlorophyll fluorescence (ST-ChlF) approaches, which carry unique potential to autonomously collect data at high spatial and temporal resolution. Over the past decades, significant progress has been made in the development and application of ST-ChlF methods in aquatic ecosystems, and in the interpretation of the resulting observations. At the same time, however, an increasing number of sensor types, sampling protocols, and data processing algorithms have created confusion and uncertainty among potential users, with a growing divergence of practice among different research groups. In this review, we assist the existing and upcoming user community by providing an overview of current approaches and consensus recommendations for the use of ST-ChlF measurements to examine in-situ phytoplankton productivity and photo-physiology. We argue that a consistency of practice and adherence to basic operational and quality control standards is critical to ensuring data inter-comparability. Large datasets of inter-comparable and globally coherent ST-ChlF observations hold the potential to reveal large-scale patterns and trends in phytoplankton photo-physiology, photosynthetic rates and bottom-up controls on primary productivity. As such, they hold great potential to provide invaluable physiological observations on the scales relevant for the development and validation of ecosystem models and remote sensing algorithms

Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and Photoreceptors

Vascular endothelial growth factor (VEGF) is well known for its role in normal and pathologic neovascularization. However, a growing body of evidence indicates that VEGF also acts on non-vascular cells, both developmentally as well as in the adult. In light of the widespread use of systemic and intraocular anti-VEGF therapies for the treatment of angiogenesis associated with tumor growth and wet macular degeneration, systematic investigation of the role of VEGF in the adult retina is critical.Using immunohistochemistry and Lac-Z reporter mouse lines, we report that VEGF is produced by various cells in the adult mouse retina and that VEGFR2, the primary signaling receptor, is also widely expressed, with strong expression by Müller cells and photoreceptors. Systemic neutralization of VEGF was accomplished in mice by adenoviral expression of sFlt1. After 14 days of VEGF neutralization, there was no effect on the inner and outer retina vasculature, but a significant increase in apoptosis of cells in the inner and outer nuclear layers. By four weeks, the increase in neural cell death was associated with reduced thickness of the inner and outer nuclear layers and a decline in retinal function as measured by electroretinograms. siRNA-based suppression of VEGF expression in a Müller cell line in vitro supports the existence of an autocrine role for VEGF in Müller cell survival. Similarly, the addition of exogenous VEGF to freshly isolated photoreceptor cells and outer-nuclear-layer explants demonstrated VEGF to be highly neuroprotective.These results indicate an important role for endogenous VEGF in the maintenance and function of adult retina neuronal cells and indicate that anti-VEGF therapies should be administered with caution

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead

Evaluation of Two Implant Strategies, Revalor- XH or a Combination Revalor- IH/Revalor- 200 on Heifer Growth Performance and Carcass Characteristics

A commercial feedlot trial examined effects of two implant strategies (Revalor- IH on d 1 and re- implanted with Revalor- 200 on d 101 or Revalor- XH on d 1) on growth performance and carcass characteristics of heifers fed 183 days. Th ere were no differences between implant strategies for final body weight, dry matter intake, and average daily gain. Heifers implanted with the combination IH/200 treatment had improved carcassadjusted feed conversion, greater LM area, and lower calculated yield grade compared to heifers implanted with XH. Th e response in growth performance between the two implant strategies suggests that the partiallycoated Revalor- XH implant can be used in place of a more aggressive implant strategy when heifers are fed to similar days